⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL459640 | 0.69 | — | — | |
| SCHEMBL13733286 | 0.62 | — | — | |
| SCHEMBL16272675 | 0.61 | MEN1 (0.32) | — | |
| SCHEMBL9122573 | 0.61 | ACHE (0.44) | — | |
| SCHEMBL2633114 | 0.61 | — | — | |
| SCHEMBL19414249 | 0.59 | — | — | |
| SCHEMBL13607127 | 0.59 | — | — | |
| SCHEMBL2633117 | 0.59 | — | — | |
| SCHEMBL17316723 | 0.59 | — | — | |
| SCHEMBL17248102 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023152371-A1 | GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA | PROQR THERAPEUTICS II B.V. (NL) | 2023-08-17 | — | — | WO | claimed |
| US-20230039928-A1 | Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease | PROQR THERAPEUTICS II B.V. (NL) | 2023-02-09 | — | — | US | claimed |
| WO-2021130313-A1 | ANTISENSE OLIGONUCLEOTIDES FOR NUCLEOTIDE DEAMINATION IN THE TREATMENT OF STARGARDT DISEASE | PROQR THERAPEUTICS II B.V. (NL) | 2021-07-01 | — | — | WO | claimed |
| EP-4400169-A2 | RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | Vico Therapeutics B.V. (NL) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024127026-A1 | MEMBRANE FILTRATION-ASSISTED SOLUTION PHASE OLIGONUCLEOTIDE SYNTHESIS | Exactmer Limited (GB) | 2024-06-20 | — | — | WO | disclosed |
| EP-3604536-B1 | RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | VICO THERAPEUTICS B V (NL) | 2024-05-29 | — | — | EP | disclosed |
| CN-118103384-A | Solution phase polymer synthesis | 艾克特姆有限公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-4370677-A1 | OLIGONUCLEOTIDE FOR INHIBITING QUAKING ACTIVITY | Academisch Ziekenhuis Leiden h.o.d.n. LUMC (NL) | 2024-05-22 | — | — | EP | disclosed |
| US-20240141340-A1 | ANTISENSE OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF CORNEAL DYSTROPHIES | PROQR THERAPEUTICS II B.V. (NL) | 2024-05-02 | — | — | US | disclosed |
| WO-2024074663-A1 | ULTRAFILTRATION METHODS | BioSpring Gesellschaft für Biotechnologie mbH (DE) | 2024-04-11 | — | — | WO | disclosed |
| EP-4349459-A1 | ULTRAFILTRATION METHODS USING OSMOLYTES ON THE PERMEATE SIDE | BioSpring Gesellschaft für Biotechnologie mbH (DE) | 2024-04-10 | — | — | EP | disclosed |
| US-6180766-B1 | OLIGONUCLEOTIDE WITH UNCHARGED INTERNUCLEOTIDE LINKAGE(S) OF 3',5'-O,O-((CARBORAN-1-YL-METHYL)PHOSPHONATE); MADE BY REACTING O-METHYL(O-CARBORAN-1-YL)METHYL PHOSPHONATE WITH PROTECTED NUCLEOSIDE; USE IN BORON NEUTRON CAPTURE THERAPY | DEPARTMENT OF VETERANS AFFAIRS | 2001-01-30 | — | — | US | disclosed |
| US-5872107-A | ANTICARCINOGENIC AGENTS CAPTURE THERAPY FOR TUMORS | EMORY UNIVERSITY (US) | 1999-02-16 | — | — | US | disclosed |
| EP-0788364-A4 | TREATMENT OF UROGENITAL CANCER WITH BORON NEUTRON CAPTURE THERAPY | UNIV EMORY (US) | 1998-05-06 | — | — | EP | disclosed |
| EP-0788364-A1 | TREATMENT OF UROGENITAL CANCER WITH BORON NEUTRON CAPTURE THERAPY | EMORY UNIVERSITY (US) | 1997-08-13 | — | — | EP | disclosed |
| EP-0731808-A4 | NUCLEOSIDES AND OLIGONUCLEOTIDES CONTAINING BORON CLUSTERS | UNIV EMORY (US) | 1997-04-02 | — | — | EP | disclosed |
| US-5599796-A | USING BORON CLUSTER-CONTAINING NUCLEOSIDES OR OLIGONUCLEOTIDES; PARTICULARLY EFFECTIVE FOR BLADDER, PROSTATE AND KIDNEY | EMORY UNIVERSITY (US) | 1997-02-04 | — | — | US | disclosed |
| EP-0731808-A1 | NUCLEOSIDES AND OLIGONUCLEOTIDES CONTAINING BORON CLUSTERS | EMORY UNIVERSITY (US) | 1996-09-18 | — | — | EP | disclosed |
| WO-1996014073-A1 | TREATMENT OF UROGENITAL CANCER WITH BORON NEUTRON CAPTURE THERAPY | EMORY UNIVERSITY (US) | 1996-05-17 | — | — | WO | disclosed |
| WO-1995015333-A1 | NUCLEOSIDES AND OLIGONUCLEOTIDES CONTAINING BORON CLUSTERS | EMORY UNIVERSITY (US) | 1995-06-08 | — | — | WO | disclosed |